EUnetHTA is pleased to announce the publication of the final project plan of its Rapid Collaborative Review on the role of antibody tests for novel coronavirus SARS-CoV-2 in the management of the current pandemic.
This is the first one of a series of Rapid Collaborative Reviews related to SARS-CoV-2 that EUnetHTA is planning to develop, and it will address research questions on several potential intended use of antibody tests, including screening, surveillance, and diagnosis.
The report is expected to be published on June 18 2020 and will be regularly updated, as new evidence is expected to become available during the next few months.
The following EUnetHTA partners are part of the review:
· Regione Emilia-Romagna (RER) as author.
· Institute for Quality and Efficiency in Health Care (IQWiG) as co-author. Health Technology Wales (HTW) joined the team as co-author after publication of the project plan.
· Health Information and Quality Authority (HIQA) as dedicated reviewer.
· Austrian Institute for Health Technology Assessment (AIHTA) as project manager.
Access the final project plan here:
